Novartis Oncology Director of Finance Salaries in Crestview, FL | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Director of Finance Salaries in Crestview, FL

The average Novartis Oncology Director of Finance in Crestview, FL earns an estimated $144,091 annually. Novartis Oncology's Director of Finance compensation is $17,925 less than the US average for a Director of Finance.

In Crestview, FL, The Finance Department at Novartis Oncology earns $14,735 more on average than the Customer Support Department.

Last updated 3 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$144,091
Average Compensation
$144,091
avg. base

Director of Finance Salaries at Novartis Oncology

In Crestview, FL, Directors of Finance earn $25,189 more than Accounting Managers.

Accounting Manager
$119k*
Senior Accountant
$90k*
Financial Analyst
$90k*
Business Analyst
$88k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Crestview, FL, The Finance Department averages $14,735 more than the Customer Support Department, and $8,543 less than the Operations Department

Operations
$89,724 Avg. total comp.
+$9k
Finance
$81,181 Avg. total comp.
Customer Support
$66,446 Avg. total comp.
-$15k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Novartis Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Novartis Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Novartis Oncology Rate Their Compensation

The majority of Directors of Finance at Novartis Oncology believe they're not compensated fairly. 100% of Directors of Finance at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company